Author/Creator: Berglund, Peter - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Berglund, Peter

11. Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio. Issue 2 (11th November 2020)

Authors:: Crosby, Erika J; Hobeika, Amy C; Niedzwiecki, Donna; Rushing, Christel; Hsu, David; Berglund, Peter; Smith, Jonathan; Osada, Takuya; Gwin III, William R; Hartman, Zachary C; Morse, Michael A; Lyerly, Herbert Kim
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 8:Issue 2(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

12. Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio. Issue 2 (11th November 2020)

Authors:: Crosby, Erika J; Hobeika, Amy C; Niedzwiecki, Donna; Rushing, Christel; Hsu, David; Berglund, Peter; Smith, Jonathan; Osada, Takuya; Gwin III, William R; Hartman, Zachary C; Morse, Michael A; Lyerly, Herbert Kim
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 8:Issue 2(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

13. Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio. Issue 2 (11th November 2020)

Authors:: Crosby, Erika J; Hobeika, Amy C; Niedzwiecki, Donna; Rushing, Christel; Hsu, David; Berglund, Peter; Smith, Jonathan; Osada, Takuya; Gwin III, William R; Hartman, Zachary C; Morse, Michael A; Lyerly, Herbert Kim
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 8:Issue 2(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

14. Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio. Issue 2 (11th November 2020)

Authors:: Crosby, Erika J; Hobeika, Amy C; Niedzwiecki, Donna; Rushing, Christel; Hsu, David; Berglund, Peter; Smith, Jonathan; Osada, Takuya; Gwin III, William R; Hartman, Zachary C; Morse, Michael A; Lyerly, Herbert Kim
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 8:Issue 2(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

15. Nonclinical safety evaluation of two vaccine candidates for herpes simplex virus type 2 to support combined administration in humans. Issue 4 (22nd November 2022)

Authors:: Piras, Fabienne; Plitnick, Lisa M.; Berglund, Peter; Bernard, Marie‐Clotilde; Desert, Paul
Journal:: Journal of applied toxicology
Issue:: Volume 43:Issue 4(2023)
Page Start:: 534
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

16. Structural brain changes in hyperthyroid Graves' disease: protocol for an ongoing longitudinal, case-controlled study in Göteborg, Sweden—the CogThy project. Issue 11 (3rd November 2019)

Authors:: Holmberg, Mats Olof; Malmgren, Helge; Berglund, Peter; Bunketorp-Käll, Lina; Heckemann, Rolf A; Johansson, Birgitta; Klasson, Niklas; Olsson, Erik; Skau, Simon; Nystrom Filipsson, Helena
Journal:: BMJ open
Issue:: Volume 9:Issue 11(2019)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

17. Therapeutic efficacy of PD1/PDL1 blockade in B16 melanoma is greatly enhanced by immunization with dendritic cell-targeting lentiviral vector and protein vaccine. Issue 17 (9th April 2020)

Authors:: Albershardt, Tina Chang; Parsons, Andrea Jean; Reeves, Rebecca Susan; Flynn, Patrick Alexander; Campbell, David James; ter Meulen, Jan; Berglund, Peter
Journal:: Vaccine
Issue:: Volume 38:Issue 17(2020)
Page Start:: 3369
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

18. ZVex™, a dendritic-cell-tropic lentivector, primes protective antitumor T cell responses that are significantly boosted using heterologous vaccine modalities. Issue 41 (22nd September 2020)

Authors:: Leleux, Jardin A.; Albershardt, Tina C.; Parsons, Andrea J.; ter Meulen, Jan; Berglund, Peter
Journal:: Vaccine
Issue:: Volume 38:Issue 41(2020)
Page Start:: 6367
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗